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ABSTRACT
Bioinformatics testing approaches for protein aller-
genicity, involving amino acid sequence compari-
sons, have evolved appreciably over the last several
years to increased sophistication and performance.
EVALLER, the web server presented in this article is
based on our recently published ‘Detection based
on Filtered Length-adjusted Allergen Peptides’
(DFLAP) algorithm, which affords in silico determi-
nation of potential protein allergenicity of high
sensitivity and excellent specificity. To strengthen
bioinformatics risk assessment in allergology
EVALLER provides a comprehensive outline of its
judgment on a query protein’s potential allergeni-
city. Each such textual output incorporates a
scoring figure, a confidence numeral of the assign-
ment and information on high- or low-scoring
matches to identified allergen-related motifs,
including their respective location in accordingly
derived allergens. The interface, built on a modified
Perl Open Source package, enables dynamic and
color-coded graphic representation of key parts of
the output. Moreover, pertinent details can be
examined in great detail through zoomed views.
The server can be accessed at http://bioinformatics.
bmc.uu.se/evaller.html.
INTRODUCTION
Allergy, including food allergy, is a major and increasing
ailment (1). The disease is strictly associated with atopy,
i.e. a genetic predisposition to develop allergic immune
reactions to otherwise innocuous components, generally
proteins. Several forms of this disorder are described and a
major one is designated IgE-mediated allergy, also known
as hypersensitivity type I (2). This disease involves
reactions to a variety of aerial proteins typically occurring
in tree, grass and weed pollen as well as proteins present in
a wide range of foods. Animal dander and insect venoms
can also cause disease reactions (3). The establishment of
allergy consists of two separate phases: sensitation and
triggering, i.e. education of the immune system and the
actual reaction(s), respectively. The former part involves
maturation of naı¨ve T- and B-cells into immunocompetent
eﬀector cells, as dictated by a series of complex cellular
interactions (4,5). The type-2 helper T-lymphocyte (TH2)
has a key function in this process, since it preferentially
promotes class switch to IgE-expression. Moreover, a
variety of regulatory T-cell subsets play an essential
function in the orchestration of an immunological
educational procedure (6,7). IgE immunoglobulins can
readily bind to high-aﬃnity receptors on tissue mast cells
or basophilic granulocytes. The triggering phase is
commenced by renewed contact with the antigen, involv-
ing binding to cell-anchored IgE molecules and an
accordingly elicited release of inﬂammatory substances,
causing anyone or several among a range of symp-
toms (8–10). Asthma, rhinitis, rhinoconjunctivitis,
eczema, contact dermatitis, angioedema and abdominal
pain are common allergic reactions, but anaphylactic
shock—entailed to impaired respiratory and circulatory
function—can also follow.
A sensitized individual may also respond similarly to
substances that share certain structural features with
the molecule that elicited the initial immune reaction
(11–13). This phenomenon, designated cross-reactivity,
is tightly connected to the epitopes, i.e. parts of an
allergenic protein that are recognized by immuno-
globulins—particularly IgE—or receptors present on
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engage either IgE- or T-cell epitopes, but that involving
IgE-binding (generally referred to as B-cell cross-
reactivity) is much better understood (14–16). IgE
epitopes can occur either as uninterrupted segments of
amino acid residues (continuous epitopes) or distributed
as patches on the protein (discontinuous epitopes), the
latter sort being brought into juxtaposition in a native
(folded) protein conﬁguration. Some common examples of
IgE-type cross-reactivity are the pollen-fruit and the latex-
fruit syndromes, both categories being associated with
promiscuous IgE recognition due to protein structural
similarity across species (12,17,18). This phenomenon
typically, but not necessarily, occurs between protein
allergens from phylogenetically related species (3,19,20).
Moreover, a relatively high degree of identity at the amino
acid sequence level is commonly seen between IgE cross-
reactive proteins (21). Nonetheless, high levels of homol-
ogy without conservation of allergenicity and low degree
of sequence similarity with conservation of the oﬀending
property are also reported (20,22).
The complex mechanisms involved in allergy have
prompted for several inherently diﬀerent methods to
safely conclude on potential protein allergenicity.
Major schemes suggest a tiered set of tests involving
amino acid sequence comparison (simple bioinformatics)
as well as several in vitro and in vivo assays (23,24).
Notably, bioinformatics-type inspection represents a key
prescription for allergenicity testing in the subsequently
adopted Codex Alimentarius guideline on safety assess-
ment of genetically modiﬁed foods and that of the
European Food Safety Authority (EFSA) (25,26). The
Codex Alimentarius bioinformatics testing scheme, being
an early computational design, is built to recognize both
general homology-type similarity (to known allergens) and
B-cell epitopes; T-cell counterparts may, though, be
outside the remit of this allergenicity assessment (25).
Intricate relationships between amino acid sequence
similarity of query proteins to known allergens and their
type-I hypersensitivity potential have, however, spurred
further development within this ﬁeld of risk assessment.
Dedicated comparison approaches in conjunction with
statistical learning algorithms have enabled increasing
overall performance of computational assessment metho-
dology (27–32).
Over the last decade, a variety of Internet-based
bioinformatics testing tools for protein potential aller-
genicity have been developed (31–35). Recently, we
reported an in silico method for evaluation of potential
protein allergenicity, designated ‘Detection based on
Filtered Length-adjusted Allergen Peptides’ (DFLAP)
(30). This system is founded on a novel principle, which
involves two main features: First, a ﬂexible peptide-
selection procedure from allergens, as accomplished by
comparing allergens with presumed non-allergens, and
secondly, speciﬁc education of an support vector machine
(SVM) to which a query amino acid sequence can be
presented.
In this article, we present EVALLER, a web server-
based on a DFLAP core algorithm and an intuitive
interface that allows for expedient interrogation of query
amino acid sequences, occurring in FASTA format.
Subsequent to processing by the DFLAP machine
EVALLER returns an assessment of its potential aller-
genicity, viewed as a rather comprehensive textual and
graphical output. EVALLER should be feasible for
scanning purposes and as a key part of an integrated
allergenicity assessment procedure.
MATERIALS AND METHODS
EVALLER is basedon theDFLAP algorithm
The EVALLER server is built as a Perl front end on top of
a DFLAP original core, which is implemented in
MATLAB. Brieﬂy, the DFLAP algorithm was allowed
to construct a set of ‘Filtered Length-adjusted Allergen
Peptides’ (FLAPs), derived by extraction from an allergen
database through a process involving comparison with a
data set (largely compiled from the human proteome)
holding proteins with low probability of being allergenic.
Selection criteria for both data sets are described else-
where (30). Amino acid sequences of both allergenic and
presumably non-allergenic proteins were subsequently
compared with the accordingly extracted FLAPs. Based
on the resulting similarity score values for each protein, an
SVM was ultimately educated to decide whether a query
protein is suﬃciently akin to any FLAP to be assigned as
an allergen. The allergen data set (762 amino acid
sequences), the non-allergen set for FLAP extraction,
(52081 amino acid sequences) and that of presumable
non-allergens for DFLAP training (1524 amino acid
sequences) were identical to those reported in our earlier
study (30). This also applies to DFLAP parameter settings
in EVALLER (minimal peptide length lmin¼22, FLAP
threshold¼48, number of FLAP matches n¼4 and the
cost parameter C¼100 in SVM). For details on these
parameters and on the algorithm, see Soeria-Atmadja
et al. (30). In its present conﬁguration, EVALLER permits
updates of both data and system. Nonetheless, eﬀorts are
underway to confer enhanced technical simplicity to this
function.
EVALLER assignment uncertainty
A decision statistic, DFLAP score, being an output
parameter by SVM algorithm of DFLAP, assigns a
query protein as either presumably an allergen or
presumably not an allergen depending on whether the
aforementioned number is positive or negative. A
conﬁdence measure accompanies each risk assessment in
order to inform the user on EVALLER’s uncertainty
regarding assignments. This measure is derived from
decision statistics of a test set (not used in the design
procedure) holding both allergens and presumed non-
allergens. While we needed to hold some data outside the
design procedure a DFLAP system was trained using two
sets encompassing 500 allergens and 1000 presumed non-
allergens, respectively, employed in our earlier published
report (30), of which the latter data set was created by
random sampling from Swiss-Prot. To achieve minimal
incorporation of spurious entries into the non-allergen set,
amino acid sequences shorter than 50 amino acid residues
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were dismissed. Compliance with the last criterion was
accomplished by alignment, allowing a maximum Smith–
Waterman score of 100 to be considered as a presumed
non-allergen. An identical procedure was applied to
compiling a test set of 1000 presumed non-allergens.
These test examples are, however, easily assigned as
presumable non-allergens by DFLAP. Therefore, addi-
tional examples of this category, which are more diﬃcult
to assess, were also included (104 vertebrate tropomyo-
sins, 39 animal proﬁlins and 14 mammalian parvalbu-
mins). Of the total 762 allergens the remaining 262
allergens, set apart from the design procedure, were used
to estimate decision statistics typical for allergens (all
sequence data sets are publicly available on the
EVALLER server, under ‘Supplementary Data’). Thus,
decision statistics for 1157 (1000þ157) presumed non-
allergens and 262 allergens were estimated, using the
accordingly designed DFLAP system. Uncertainty scores
(US) are diﬀerently deﬁned for allergen assignments (i.e.
the decision statistic DFLAP score >0), relative to those
of presumed non-allergens (i.e. the decision statistic
DFLAP score <0). Both deﬁnitions are speciﬁed as the
uncertainty, given that the DFLAP score served as a
decision threshold instead of zero. In the former (allergen)
case, the uncertainty score reﬂects the probability of false
alarms (1-speciﬁcity), whereas the probability of over-
looking an allergen (1-sensitivity) applies to the latter
(non-allergen) situation:
if DFLAPscore >0;US DFLAPscore ðÞ ¼
FP DFLAPscore ðÞ
TN DFLAPscore ðÞ þ FP DFLAPscore ðÞ
1
If DFLAPscore <0;US DFLAPscore ðÞ ¼
FN DFLAPscore ðÞ
TP DFLAPscore ðÞ þ FN DFLAPscore ðÞ
2
FN(DFLAP score) and TP(DFLAP score) are numbers
of misclassiﬁed and correctly assigned allergens, respec-
tively, when test statistic DFLAP score is used as a
decision threshold. Analogously, FP(DFLAP score) and
TN(DFLAP score) are the numbers of incorrect/correct
assignments of presumed non-allergens, when DFLAP
score applies as a decision threshold.
RESULTS AND DISCUSSION
EVALLER web server
EVALLER was developed to enable bioinformatics
assessment of protein potential allergenicity by virtue of
the corresponding amino acid sequences. In its present
design, protein sequences occurring in FASTA format are
accepted. The interrogation procedure, involving submis-
sion of a query amino acid sequence (one at a time), allows
for user-deﬁned options regarding presentation of results;
a range of top-scoring matches and resizable views of the
test sequence and matching peptides (Figure 1). Detector
design and classiﬁcation of the test sequence are, however,
not available to the user since parameters involved in these
procedures have already been optimized (30).
As outlined in ‘Material and Methods’ section, the
EVALLER decision statistic for allergenic potential has
been split into two separate categories: ‘presumably not an
allergen’ and ‘presumably an allergen’. An uncertainty
score, indicating the conﬁdence level of EVALLER, is also
presented. It is based on the decision statistics from
interrogation of a reduced DFLAP, i.e. 262 allergens and
1157 presumed non-allergens (see ‘Material and Methods’
section). An uncertainty score for a negative (presumably
a non-allergen) decision statistic, DFLAP score, repre-
sents the probability of neglecting an allergen, assuming
that the decision threshold had been set at the DFLAP
score instead of zero. Analogously, an uncertainty score
based on a positive (presumably an allergen) DFLAP
score indicates the probability of false alarm, on the
assumption that the DFLAP score is identical to the
decision threshold. Uncertainty score numbers decrease
with increased distance of the DFLAP score to the
Figure 1. Flow-chart outlining procedural steps to arrive at the algorithmic core of EVALLER and functions available to the user.
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EVALLER is much more conﬁdent in its assignment to
the ‘presumably an allergen’ category than that of non-
allergens. The uncertainty scores are estimated for a
reduced DFLAP (educated with 500 allergens and 1000
presumed non-allergens) rather than for the ﬁnal DFLAP
that EVALLER is based upon (762 allergens and 1524
presumed non-allergens), and may therefore be overly
conservative. For clarity, the textual assignment output
has been color-coded as determined by category
(Figure 3). Green color indicates low allergenic potential
whereas red corresponds to a presumable allergen, as
judged by EVALLER.
A 2D graphic representation of the scanned sequence,
alongside with a color-coded printout (according to the
aforementioned assignment scheme) of best matching
FLAPs, are presented to the user by virtue of a modiﬁed
version of the Perl open source package EBioForms
(unpublished). The display is dynamic and can be zoomed
for detailed views of speciﬁc parts of the sequence
(Figure 3). Apart from presumed allergen/presumed
non-allergen assignment, being integrated in the afore-
mentioned view, EVALLER also provides information on
FLAP (see ‘Materials and Methods’ section) to which
similarity is identiﬁed (Figure 3). Moreover, a link to
the UniProt of the cognate allergen accompanies each
FLAP. The server and related information is available
at the following Internet address: http://bioinformatics.
bmc.uu.se/evaller.html.
Benchmarking EVALLER withcalcium-binding proteins;
comparison withother web servers
The EVALLER core algorithm has been extensively
validated for sensitivity and false-alarm rates, using test
sets of amino acid sequences (30). Nonetheless, several
potential allergens of the polcalcin family of proteins,
being members of a widely known protein family involved
in pollen–pollen cross-sensitization (36), were not included
in those evaluations and may therefore qualify as feasible
for a simple test of EVALLER performance. Polcalcins
hold two EF-hand calcium-binding domains and typically
show high intra-family sequence similarity (37).
Presumable non-allergenic homologues to the polcalcin
family include the calmodulins and calmodulin-like
proteins, as well as other related calcium-binding proteins.
An assembly of these proteins, derived from both plant
and animal kingdoms, were mined from UniProt and
interrogated for potential allergenicity by EVALLER as
well as by two additional web servers—Allermatch and
APPEL—dedicated to assessment of potential allerge-
nicity (32,34). The former of these already reported
methods is designed to apply bioinformatics testing
principles outlined by the Codex Alimentarius
Commission, i.e. either >35% identity in a segment of
80 amino acid residues (criterion 1) alone or in conjunc-
tion with an exact match in stepwise searches for
continuous identical sequence segments (criterion 2),
whereas the latter implementation derives an assessment
from sequence-derived structural and physicochemical
properties in combination with an SVM (25,32,34). The
EVALLER and APPEL servers assigned all calmodulins
or calmodulin-like proteins as presumably non-allergenic,
whereas a traditional alignment approach (35% similarity
over 80 amino acid segments) gives preference to
resemblance of input proteins to known allergens
(Table 1). Although EVALLER and Allermatch diﬀer in
assignment on (presumably non-allergen) query proteins,
both methods identiﬁed peptides (or entire amino acid
sequences) in allergen polcalcins as best matches. In two
cases, however, EVALLER reported diﬀerently. The top-
scoring FLAP hits for calcium-binding protein-5 (bovine
and human) are derived from a troponin-like protein
occurring in the ﬁsh parasite Anisakis simplex. This
protein, however, also contains EF-hand Ca
2þ binding
motifs, typical of polcalcins, which confers reason to its
identiﬁcation by the EVALLER algorithm (38).
Furthermore, to probe for sensitivity of the aforemen-
tioned web servers, three polcalcins—neither of them
incorporated in the EVALLER system—were submitted
for interrogation. Two of them occur in tobacco and one
(Syr v 3) in lilac (Table I). The Allermatch database
already holds these potential allergens, thereby easily
ﬁnding perfect matches. Both EVALLER and APPEL,
though, assigned Syr v 3 as presumably allergenic, a
conclusion supported by a recent report (39). The two
tobacco polcalcins were also recognized as potential
allergens. For the time being, though, these proteins are
devoid of documentation on allergenicity in the scientiﬁc
literature. Although scored as allergens by EVALLER
and the two additional bioinformatics testing tools
referred to above, further interrogation is needed to
arrive at a scientiﬁcally justiﬁed conclusion on the
allergenicity of the three polcalcin proteins. For this
purpose, immunoassay analysis, involving reactivity mea-
surement of IgE antibodies in the sera of patients with
clinically validated allergic responses to other polcalcins
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Figure 2. Graph depicting the level of uncertainty depending on the
decision statistic obtained from EVALLER assignment. The uncer-
tainty is deﬁned as the probability of an erroneous assessment assuming
the decision threshold is set at the decision statistic instead of zero.
Under this condition, the solid line illustrates the probability of
neglecting an allergen when EVALLER assigns an amino acid sequence
as a presumable non-allergen. The dashed curve illustrates the
probability of obtaining a false alarm when EVALLER assigns an
amino acid sequence as a presumable allergen.
Nucleic Acids Research, 2007, Vol. 35, WebServerissue 697Figure 3. Snapshots of the EVALLER output page subsequent to assessment of potential allergenicity for amino acid sequences. Colored (green or
red) bars indicate FLAPs, being part of a data set generated by a ﬁltration process as particular for allergenic proteins. The presumably non-
allergenic human calmodulin (A) as well as the likely allergenic polcalcin (Syr v 3) from lilac (B). A zoomed-in view focusing between amino residues
at position 25 and 50 of the presumed allergen Syr v 3 is also shown (C).
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digestion under appropriate conditions, may further
improve assessment accuracy (25,40).
EVALLER inthe context ofvarious approachesto
bioinformatics-type risk assessment ofprotein potential
allergenicity
Most of the hitherto accumulated literature on bioinfor-
matics protein allergenicity assessment can be assorted
into any of the following several categories: straightfor-
ward alignment (e.g. the Codex two-part procedure),
alignment-based feature-extraction combined with statis-
tical learning, methods based on comparison to either
allergen-derived motifs or reported IgE epitopes and,
lastly, similarity search of entire proteins as represented by
a variety of coding protocols (27,28,32,41–46). Moreover,
by bringing a special kind of segment-reduction procedure
into action on allergens, the alignment/statistical learning
model has been considerably enhanced (29,30). Hence,
EVALLER—built on a DFLAP core—exploits on a
tripartite procedure, including a highly specialized
ﬁltration of peptides from allergens involving usage of
the human proteome, to create material, which permits
eﬃcient education of an SVM algorithm. Each output,
in response to query submission, is accompanied
by an uncertainty numeral, which allows the user to
appraise assignment accuracy. Additionally, parts of the
query proteins deemed most akin to cognate segments
in any or several among the local repository of
allergens, are depicted and made available to users of
EVALLER in several ways, which altogether support risk
assessment.
SUPPLEMENTARY DATA
Supplementary data are available at NAR Online.
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